Decoding Dengue

Decoding Dengue

Thursday, December 11th 2025 - 3:00 PM (IST)

6 days to go

213 doctors attending

Thursday, December 11th 2025 - 3:00 PM (IST)

Medflix

About this session

This focused dengue awareness session brings together expert clinicians to address the rising disease burden, prevention strategies, and the unmet need for a safe and effective vaccine, followed by a discussion on a novel dengue vaccine. The program begins with an insightful overview of dengue by Dr. B. Bhaskar Raju, followed by a high-value panel discussion featuring Dr. A.V. Ravishankar and Dr. Priya Biswakumar, moderated by Dr. Bhaskar Raju. The session concludes with an audience Q&A, offering practical perspectives on dengue management.

Faculty

Key details

Registration

Free

Duration

60 min

Replay

Yes

Certificate

No

Language

English

Supported by

Supported By

Explore other sessions

Peripheral Neuropathies: Rare causes and workup beyond Diabetes

Peripheral Neuropathies: Rare causes and workup beyond Diabetes

5 December 2025 | 3:30 PM (IST)

Disclaimer

This information is solely intended for the use of Registered Healthcare Practitioner / Registered Medical Practitioner only. The information contained herein is based on the published medical literature and international recommended guidelines. The information provided is intended for educational purposes only, aimed at increasing awareness on dengue and not meant for promotion of any specific product. Registered Healthcare Practitioner / Registered Medical Practitioner shall apply their independent medical judgement for diagnosing or assessing or treating any patient. Takeda makes no representation or warranty concerning the information / content provided and assumes no responsibility for the accuracy of the information or content or opinion furnished, or any outcome based on the application of such information. This material contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution. TAK-003 has not been approved for the use or indications under investigation in the clinical trials in India (and there is no guarantee it will be approved for such use or indication). Claims of safety and effectiveness can only be made after regulatory review of the data and approval of the labelled claims. TAKEDA and the TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.

VV-MEDMAT-130152